• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

A New York based ALS research organization that's leading the fight for a cure.

  • DONATE
  • About Us
    • Our Mission
    • Our Model
    • Our Impact
    • Our Founder
    • Our Team
    • Our Partners
  • For Scientists
    • Research Cores
      • Target ALS Data Engine
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Stem Cell Core
      • Reagents Core
      • Animal Models Core
    • Funding Opportunities
    • Funded Projects
    • Annual Meeting
    • Science on Target Blog
  • Understanding ALS
    • About ALS
    • Understanding the Science
      • Glossary
      • FAQ
      • ALS 101
    • Voices of ALS
    • Video Library
  • Take Action
    • Support Geoff Greulich
    • The ALS Global Research Initiative (AGRI)
      • Global Natural History Study
      • Community Based Pop-Up Clinics
    • Ways to Give
    • Email Sign Up
    • Contact Us
    • Donate Now
  • News
    • Announcements
    • In the News
    • Newsletters & Reports

Glossary

Amyotrophic lateral sclerosis, more commonly known as ALS, is a progressive neurodegenerative disease in the central nervous system that impacts the brain and spinal cord, resulting in a loss of muscle control.

It is colloquially referred to as Lou Gehrig’s Disease, after the famous baseball player who battled it in the late 1930s, and does not yet have a cure. To better understand the language of ALS, the ALS Glossary below provides definitions for research terms commonly used by our Innovation Ecosystem and the extended ALS community.

ABCDEFGHIKLMNPRSTUWAll

metadata

Information describing data. In genomic research, metadata includes where/how the DNA or RNA sequence was obtained, allowing researchers to reproduce or retrieve data more easily.

motor neuron disease

A group of disorders in which motor nerve cells (neurons) in the spinal cord and brain stem deteriorate and die. ALS is the most common motor neuron disease

multiple sclerosis (MS)

An autoimmune disease affecting the central nervous system. MS involves the gradual destruction of myelin (the protective covering of nerves) throughout the brain and/or spinal cord. This interferes with nerve pathways, causing muscular weakness, loss of coordination and speech and visual disturbances.

muscle atrophy

Loss of muscle fiber volume that leads to a visible decrease in muscle size.

muscular dystrophy (MD)

A group of muscle diseases caused by progressive muscle degeneration and weakness due to the alterations of proteins involved in muscle health.

myasthenia gravis (MG)

A chronic autoimmune, neuromuscular disease that causes weakness and fatigue in the skeletal muscles, affecting the eyes, face, neck, and limbs. Its name means "grave muscular weakness."

Footer

Target ALS
  • Donate
  • Contact
  • Financial Reports
  • Call For Proposals
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140
Steck Insights WordPress Consulting

Get our Summer Impact Report in your inbox – a special recap of our Annual Meeting and the progress we're making in ALS research.

Name(Required)
Interests(Required)
Mark the options that best describe your interest in ALS